ARRON WRIGHT: Open Payments
NPI 1568177988 · MOUNT LAUREL, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,593 in 86 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $583 · 2025 $1,593
Food & beverage: $1,593
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 20 | $415 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $291 |
| ABBVIE INC. | 19 | $261 |
| Supernus Pharmaceuticals, Inc. | 14 | $146 |
| Biogen, Inc. | 1 | $106 |
| Lundbeck LLC | 4 | $74 |
| Janssen Pharmaceuticals, Inc | 4 | $71 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $55 |
| Alkermes, Inc. | 3 | $55 |
| Corium, LLC | 4 | $51 |
Products named: REXULTI, CAPLYTA, VRAYLAR, Qelbree, ZURZUVAE, SPRAVATO, TRINTELLIX, LYBALVI.
Industry payments across NJ — which companies pay providers there.
